Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3427353
Max Phase: Preclinical
Molecular Formula: C16H18N4O2
Molecular Weight: 298.35
Molecule Type: Small molecule
Associated Items:
ID: ALA3427353
Max Phase: Preclinical
Molecular Formula: C16H18N4O2
Molecular Weight: 298.35
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Oc1ccc(/C=N/N2CCN(c3ccncc3)CC2)c(O)c1
Standard InChI: InChI=1S/C16H18N4O2/c21-15-2-1-13(16(22)11-15)12-18-20-9-7-19(8-10-20)14-3-5-17-6-4-14/h1-6,11-12,21-22H,7-10H2/b18-12+
Standard InChI Key: UQSWIBWJURSBPJ-LDADJPATSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 298.35 | Molecular Weight (Monoisotopic): 298.1430 | AlogP: 1.65 | #Rotatable Bonds: 3 |
Polar Surface Area: 72.19 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.95 | CX Basic pKa: 8.37 | CX LogP: 0.79 | CX LogD: 0.62 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.84 | Np Likeness Score: -0.96 |
1. Mayer N, Schweiger M, Melcher MC, Fledelius C, Zechner R, Zimmermann R, Breinbauer R.. (2015) Structure-activity studies in the development of a hydrazone based inhibitor of adipose-triglyceride lipase (ATGL)., 23 (12): [PMID:25778769] [10.1016/j.bmc.2015.02.051] |
Source(1):